Summary
In 2016, the World Health Assembly launched the WHO’s ‘End TB strategy’; an ambitious project to reduce TB incidence by 90% before 2035 and progress to 1 TB case per million in 2050 worldwide. Effective routes to TB elimination are, among others, optimized treatment regimens to shorten treatment duration and better diagnostic methods. Unfortunately, advances are very slow due to a huge lack of funding and clinical research capacity to conduct trials. The TB research community needs to be both creative and innovative to build and strengthen existing capacity as well as to expand clinical trial networks to perform more cost- and time effective drug- and diagnostic trials.
With this RISE proposal we aim to strenghten the European-Latin American TB Research Collaboration Network (EUSAT-RCS), offer capacity building for Paraguayan and European TB professionals and build up a Latin American TB clinical hub.
A group of ESRs, ERs, TECH and other professionals are brought together to carry out clinical research spanning epidemiology of TB in populations to GWAS and the validation of an innovative eNose device for point-of-care diagnostic value.
With this RISE proposal we aim to strenghten the European-Latin American TB Research Collaboration Network (EUSAT-RCS), offer capacity building for Paraguayan and European TB professionals and build up a Latin American TB clinical hub.
A group of ESRs, ERs, TECH and other professionals are brought together to carry out clinical research spanning epidemiology of TB in populations to GWAS and the validation of an innovative eNose device for point-of-care diagnostic value.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/823890 |
| Start date: | 01-04-2019 |
| End date: | 31-03-2024 |
| Total budget - Public funding: | 910 800,00 Euro - 910 800,00 Euro |
Cordis data
Original description
In 2016, the World Health Assembly launched the WHO’s ‘End TB strategy’; an ambitious project to reduce TB incidence by 90% before 2035 and progress to 1 TB case per million in 2050 worldwide. Effective routes to TB elimination are, among others, optimized treatment regimens to shorten treatment duration and better diagnostic methods. Unfortunately, advances are very slow due to a huge lack of funding and clinical research capacity to conduct trials. The TB research community needs to be both creative and innovative to build and strengthen existing capacity as well as to expand clinical trial networks to perform more cost- and time effective drug- and diagnostic trials.With this RISE proposal we aim to strenghten the European-Latin American TB Research Collaboration Network (EUSAT-RCS), offer capacity building for Paraguayan and European TB professionals and build up a Latin American TB clinical hub.
A group of ESRs, ERs, TECH and other professionals are brought together to carry out clinical research spanning epidemiology of TB in populations to GWAS and the validation of an innovative eNose device for point-of-care diagnostic value.
Status
SIGNEDCall topic
MSCA-RISE-2018Update Date
28-04-2024
Images
No images available.
Geographical location(s)
Search
